139 related articles for article (PubMed ID: 38114736)
1. Novel Selective Quantification of Zinpentraxin Alfa Biotherapeutic in the Presence of Endogenous Isomer in Plasma Samples of Idiopathic Pulmonary Fibrosis Patients Using Immunoaffinity LC-MS.
Li M; Arjomandi A; Sun X; Lu E; Tyagi T; Lin W; Fischer SK; Kaur S; Xu K
AAPS J; 2023 Dec; 26(1):9. PubMed ID: 38114736
[TBL] [Abstract][Full Text] [Related]
2. Zinpentraxin Alfa for Idiopathic Pulmonary Fibrosis: The Randomized Phase III STARSCAPE Trial.
Richeldi L; Schiffman C; Behr J; Inoue Y; Corte TJ; Cottin V; Jenkins RG; Nathan SD; Raghu G; Walsh SLF; Jayia PK; Kamath N; Martinez FJ
Am J Respir Crit Care Med; 2024 May; 209(9):1132-1140. PubMed ID: 38354066
[No Abstract] [Full Text] [Related]
3. Repeat-dose and embryo-fetal developmental toxicity of zinpentraxin alfa.
Rao GK; Santagostino SF; Wong L; Inoue A; Arjomandi A; Yadav R; Halpern WG
Reprod Toxicol; 2024 Jan; 123():108526. PubMed ID: 38141866
[TBL] [Abstract][Full Text] [Related]
4. Comparative Pharmacokinetics and Safety Assessment of 1st- and 2nd-Generation Zinpentraxin Alfa Drug Products in Healthy Volunteers: A Randomized Crossover Study.
Mai TH; Yadav R; Arjomandi A; Jung C; Meier MM; Donaldson F; Zhao R; Ding HT; Hsu JC; Kamath N; Pan L
Clin Pharmacol Drug Dev; 2024 Jun; 13(6):655-664. PubMed ID: 38651245
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of multiple immunoassay formats for detection of anti-drug antibodies to zinpentraxin alfa.
Yang X; Siradze K; Sperinde G; Arjomandi A; Fischer S
J Immunol Methods; 2023 Nov; 522():113573. PubMed ID: 37816404
[TBL] [Abstract][Full Text] [Related]
6. Isomeric Separation of α2,3/α2,6-Linked 2-Aminobenzamide (2AB)-Labeled Sialoglycopeptides by C18-LC-MS/MS.
Jiang P; Huang Y; Gutierrez Reyes CD; Zhong J; Mechref Y
Anal Chem; 2023 Dec; 95(50):18388-18397. PubMed ID: 38069741
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of zinpentraxin alfa as monotherapy or in combination with ruxolitinib in myelofibrosis: stage I of a phase II trial.
Verstovsek S; Foltz L; Gupta V; Hasserjian R; Manshouri T; Mascarenhas J; Mesa R; Pozdnyakova O; Ritchie E; Veletic I; Gamel K; Hamidi H; Han L; Higgins B; Trunzer K; Uguen M; Wang D; El-Galaly TC; Todorov B; Gotlib J
Haematologica; 2023 Oct; 108(10):2730-2742. PubMed ID: 37165840
[TBL] [Abstract][Full Text] [Related]
8. Successful Development of Nonclinical Anti-Drug Antibody Assays to Support Zinpentraxin Alfa Reproductive Toxicology Studies.
Arjomandi A; Siradze K; Cheu M; Davancaze T; Yadav R; Rao GK; Wong L; Fischer SK
AAPS J; 2024 Jan; 26(1):16. PubMed ID: 38267613
[TBL] [Abstract][Full Text] [Related]
9. Reduced Sialylation and Bioactivity of the Antifibrotic Protein Serum Amyloid P in the Sera of Patients with Idiopathic Pulmonary Fibrosis.
Chen W; Karhadkar TR; Ryu C; Herzog EL; Gomer RH
Immunohorizons; 2020 Jun; 4(6):352-362. PubMed ID: 32576593
[TBL] [Abstract][Full Text] [Related]
10. Quantification of the α2-6 Sialic Acid Linkage in Branched N-Glycan Structures with Capillary Nanogel Electrophoresis.
Bwanali L; Crihfield CL; Newton EO; Zeger VR; Gattu S; Holland LA
Anal Chem; 2020 Jan; 92(1):1518-1524. PubMed ID: 31829566
[TBL] [Abstract][Full Text] [Related]
11. Isomer separation of sialylated O- and N-linked glycopeptides using reversed-phase LC-MS/MS at high temperature.
Ji ES; Lee HK; Park GW; Kim KH; Kim JY; Yoo JS
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Mar; 1110-1111():101-107. PubMed ID: 30798070
[TBL] [Abstract][Full Text] [Related]
12. Fragmentation stability and retention time-shift obtained by LC-MS/MS to distinguish sialylated
Park CS; Kang M; Kim A; Moon C; Kim M; Kim J; Yang S; Jang L; Jang JY; Kim HH
J Pharm Anal; 2023 Mar; 13(3):305-314. PubMed ID: 37102108
[TBL] [Abstract][Full Text] [Related]
13. Human plasma trans-sialidase causes atherogenic modification of low density lipoprotein.
Tertov VV; Kaplun VV; Sobenin IA; Boytsova EY; Bovin NV; Orekhov AN
Atherosclerosis; 2001 Nov; 159(1):103-15. PubMed ID: 11689212
[TBL] [Abstract][Full Text] [Related]
14. Comparative Glycomic Analysis of Sialyl Linkage Isomers by Sialic Acid Linkage-Specific Alkylamidation in Combination with Stable Isotope Labeling of α2,3-Linked Sialic Acid Residues.
Hanamatsu H; Nishikaze T; Tsumoto H; Ogawa K; Kobayashi T; Yokota I; Morikawa K; Suda G; Sho T; Nakai M; Miura N; Higashino K; Sekiya S; Iwamoto S; Miura Y; Furukawa JI; Tanaka K; Sakamoto N
Anal Chem; 2019 Nov; 91(21):13343-13348. PubMed ID: 31577134
[TBL] [Abstract][Full Text] [Related]
15. Long-term evaluation of the safety and efficacy of recombinant human pentraxin-2 (rhPTX-2) in patients with idiopathic pulmonary fibrosis (IPF): an open-label extension study.
Raghu G; Hamblin MJ; Brown AW; Golden JA; Ho LA; Wijsenbeek MS; Vasakova M; Pesci A; Antin-Ozerkis DE; Meyer KC; Kreuter M; Burgess T; Kamath N; Donaldson F; Richeldi L
Respir Res; 2022 May; 23(1):129. PubMed ID: 35597980
[TBL] [Abstract][Full Text] [Related]
16. Effect of Recombinant Human Pentraxin 2 vs Placebo on Change in Forced Vital Capacity in Patients With Idiopathic Pulmonary Fibrosis: A Randomized Clinical Trial.
Raghu G; van den Blink B; Hamblin MJ; Brown AW; Golden JA; Ho LA; Wijsenbeek MS; Vasakova M; Pesci A; Antin-Ozerkis DE; Meyer KC; Kreuter M; Santin-Janin H; Mulder GJ; Bartholmai B; Gupta R; Richeldi L
JAMA; 2018 Jun; 319(22):2299-2307. PubMed ID: 29800034
[TBL] [Abstract][Full Text] [Related]
17. Recombinant human serum amyloid P in healthy volunteers and patients with pulmonary fibrosis.
Dillingh MR; van den Blink B; Moerland M; van Dongen MG; Levi M; Kleinjan A; Wijsenbeek MS; Lupher ML; Harper DM; Getsy JA; Hoogsteden HC; Burggraaf J
Pulm Pharmacol Ther; 2013 Dec; 26(6):672-6. PubMed ID: 23380438
[TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of isomeric N-glycans of human alfa-acid-glycoprotein by stable isotope labelling and ZIC-HILIC-MS in combination with exoglycosidase digestion.
Mancera-Arteu M; Giménez E; Barbosa J; Sanz-Nebot V
Anal Chim Acta; 2016 Oct; 940():92-103. PubMed ID: 27662763
[TBL] [Abstract][Full Text] [Related]
19. A novel strategy for quantification of α2,3- and α2,6-linked sialic acids in sialylated glycoproteins.
Wang X; Yue L; Zhang F; Tang Z; Chen Z; Li Z
Carbohydr Res; 2023 Sep; 531():108892. PubMed ID: 37429229
[TBL] [Abstract][Full Text] [Related]
20. Comparison between intact and desialylated human serum amyloid P component by laser photo CIDNP (chemically induced dynamic nuclear polarization) technique: an indication for a conformational impact of sialic acid.
Siebert HC; André S; Reuter G; Kaptein R; Vliegenthart JF; Gabius HJ
Glycoconj J; 1997 Dec; 14(8):945-9. PubMed ID: 9486427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
